AI assistant
Sending…
CONMED Corp — Director's Dealing 2024
May 8, 2024
31971_dirs_2024-05-08_330dc6b8-21a6-43b5-b96b-21f182b8522f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2024-05-06
Reporting Person: Aronson Martha Goldberg (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-05-06 | Common Stock | P | 2000 | $70.98 | Acquired | 2000 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 11610 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $70.92 to $71.19. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
More from CONMED Corp
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 18